Expansion readiness Trajan is a mid-sized global biotech player with operations across Australia, Europe, the US and Asia, indicating strong international reach and potential for regional channel partnerships, distributor agreements and localized regulatory support.

HDExaminer PRO launch Recent introduction of HDExaminer PRO v1.0 at ASMS 2026 signals a new, potentially saleable analytical platform with commercial availability, presenting opportunities for upsell to existing customers and cross-sell with complementary lab instrumentation.

Strategic partnerships Active partnerships with GenTegra and BioAnalytic suggest a pattern of collaboration to extend protection technologies and distribution for Mitra microsampling devices, indicating room for additional co-marketing, OEM, and distribution deals.

Wellness program MonitorYou Corporate Wellness initiative demonstrates a commitment to employee health and workplace engagement, creating a potential entry point for turnkey healthcare analytics, on-site testing, or data-driven wellness services for partner customers.

Financial scale With revenue in the tens of millions and a $21M funding round, Trajan shows financial bandwidth for strategic investments, pilot programs, and accelerated product validation efforts that can be leveraged in long-cycle scientific commercialization projects.